The pathogenic role of excessive type I IFN signaling is particularly evident in diseases such as Aicardi–Goutières Syndrome (AGS), where mutations in key nucleic acid regulatory proteins, such as TREX1 and ADAR1, lead to the aberrant accumulation of cytosolic nucleic acids [25,26]. This evidence concerns the gene ADAR and Aicardi-Goutieres syndrome.